. Author manuscript; available in PMC: 2019 Apr 10.

Published in final edited form as: Value Health. 2018 Aug 30;21(12):1357–1364. doi: 10.1016/j.jval.2018.06.003

Table 4.

Cost-effectiveness of the multicomponent intervention

Variable	Intervention group vs control group^*	95% CI	ICER	95% CI^**

QALY difference	0.042	(0.01 to 0.08)	3299.42	(1635.42 to 6099.06)
SBP difference, mm Hg	−5.30	(−10.34 to −0.27)	26.43	(13.08 to 45.91)
HTN control difference, %	19%	(5% to 33%)	721.42	(352.12 to 1087.60))
Total cost difference, $	140.18	(75.41 to 204.94)	-	-

Notes:

Adjusted for sex, age, SBP, history of CVD, and history of hypercholesterolemia at baseline.

^**

The 95% confidence intervals were estimated using the bootstrap method based with 1000 replications.

SBP: Systolic Blood Pressure; QALY: Quality-Adjusted Life Year; HTN: Hypertension